Back
ZyVersa Therapeutics Stock Price Chart
Sponsored
ZVSA
Sponsored
Could This Stock Under $5 Be Your Biggest Opportunity?
Click here to learn more.
Sell
23
ZVSA
ZyVersa Therapeutics
Last Price:
$1.24
Seasonality Move:
-0.51%
7 Day Trial
ALL ACCESS PASS
$
7
Today's Fastest Growing Company Might Surprise You
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and ZVSA is experiencing slight buying pressure.
ZyVersa Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.13 | Sell |
20-day SMA: | 1.1 | Sell |
50-day SMA: | 1.35 | Sell |
200-day SMA: | 3.54 | Sell |
8-day EMA: | 1.11 | Sell |
20-day EMA: | 1.13 | Sell |
50-day EMA: | 1.4 | Sell |
200-day EMA: | 32.45 | Sell |
ZyVersa Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 44.12 | Sell |
Chaikin Money Flow: | 8305 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.03 - 1.15) | Buy |
Bollinger Bands (100): | (1.24 - 2.66) | Sell |
ZyVersa Therapeutics Technical Analysis
Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for ZyVersa Therapeutics Stock
Is ZyVersa Therapeutics Stock a Buy?
-
ZyVersa Therapeutics share price is 1.09 while ZVSA 8-day simple moving average is 1.13, which is a Sell signal.
-
The stock price of ZVSA is 1.09 while ZyVersa Therapeutics 20-day SMA is 1.10, which makes it a Sell.
-
ZyVersa Therapeutics 50-day simple moving average is 1.35 while ZVSA share price is 1.09, making it a Sell technically.
-
ZVSA stock price is 1.09 and ZyVersa Therapeutics 200-day simple moving average is 3.54, creating a Sell signal.
ZVSA Technical Analysis vs Fundamental Analysis
Sell
23
ZyVersa Therapeutics (ZVSA)
is a Sell
Is ZyVersa Therapeutics a Buy or a Sell?
-
ZyVersa Therapeutics stock is rated a SellThe current ZyVersa Therapeutics [ZVSA] share price is $1.09. The Score for ZVSA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
ZyVersa Therapeutics Stock Info
Market Cap:
2.6M
Price in USD:
1.09
Share Volume:
58.1K
ZyVersa Therapeutics 52-Week Range
52-Week High:
25.00
52-Week Low:
0.98
Sell
23
ZyVersa Therapeutics (ZVSA)
is a Sell
ZyVersa Therapeutics Share Price Forecast
-
What is the ZyVersa Therapeutics stock price today?The ZyVersa Therapeutics stock price is 1.09 USD today.
-
Will ZVSA stock go up or go down?ZyVersa Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is ZyVersa Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ZyVersa Therapeutics is overvalued.
Is ZyVersa Therapeutics Stock a Buy?
-
ZyVersa Therapeutics share price is 1.09 while ZVSA 8-day exponential moving average is 1.11, which is a Sell signal.
-
The stock price of ZVSA is 1.09 while ZyVersa Therapeutics 20-day EMA is 1.13, which makes it a Sell.
-
ZyVersa Therapeutics 50-day exponential moving average is 1.40 while ZVSA share price is 1.09, making it a Sell technically.
-
ZVSA stock price is 1.09 and ZyVersa Therapeutics 200-day simple moving average is 32.45, creating a Sell signal.
Fundamental Analysis of ZyVersa Therapeutics
Is ZyVersa Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $1.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $11.20 per share, and a decrease next year of $0.00 per share.
Technical Analysis of ZyVersa Therapeutics
Should I short ZyVersa Therapeutics stock?
-
ZVSA Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting ZyVersa Therapeutics is a Sell
-
ZyVersa Therapeutics Relative Strength Index (RSI) is 44.12, which suggest ZyVersa Therapeutics is oversold
-
The Bollinger Bands (25) for ZyVersa Therapeutics is (1.03 - 1.15), which suggest ZyVersa Therapeutics is a Sell
-
The Bollinger Bands (100) for ZyVersa Therapeutics is (1.24 - 2.66), which suggest ZyVersa Therapeutics is a Sell
* ZyVersa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.